Natera is trading 4.6% down at $370.73 on November 4, 2026, with no clear company-specific announcement or verified catalyst identified.

  • Natera is scheduled to report third-quarter results after market close on November 5; the earnings preview does not establish a cause for the decline.
  • A November 4 report noted a recent CFO share sale, but there is no evidence tying it to the price move.
  • Biotech shares are higher, so sector strength does not explain Natera’s decline.